Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

PCVX stock hub

Vaxcyte, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

PCVXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.7B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

PCVX

In the news

Latest news · PCVX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-30.6

P25 -105.6P50 -46.5P75 -3.1

ROIC-21.3

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All PCVX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

184

Groups with data

Currency

USD

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001649094
Company name	Vaxcyte, Inc.
Country	United States
Country code	US
Cusip	92243G108
Employees	507
Employees Change	93%
Employees Change Percent	22.46
Enterprise value	$6B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-06-12
Isin	US92243G1085
Last refreshed	2026-05-10
Market cap	$7.7B
Market cap category	Mid-Cap
Price	$53.01
Price currency	USD
Sector	Healthcare
Sic	2836
Symbol	PCVX
Website	https://vaxcyte.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-12.37%
FCF yield	-10.65%
P/B ratio	2.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-946.5M
Net Income Growth Years	0%
Profit Per Employee	$-1.9M
ROA	-20.23
Roa5y	-19.26
ROCE	-35.05
ROE	-30.55
Roe5y	-30.11
ROIC	-21.27

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	82.87%
Cagr3y	1.03%
Cagr5y	24.62%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$3.3B
Cash	$1.7B
Current Assets	$1.8B
Current Liabilities	$242.1M
Debt	$116.3M
Debt Equity	$0.04
Equity	$3B
Liabilities	$352.3M
Long Term Assets	$1.5B
Long Term Liabilities	$110.2M
Net Cash	$1.6B
Net Cash By Market Cap	$21.18
Net Cash Growth	2.29%
Net Debt Equity	$-0.54
Tangible Book Value	$3B
Tangible Book Value Per Share	$20.76
WACC	11.23

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.49
Net Working Capital	$-159.7M
Quick ratio	7.18
Working Capital	$1.6B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-7.07%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	82.79%
200-day SMA	46.65
3Y total return	3.13%
50-day SMA	58.15
50-day SMA vs 200-day SMA	50over200
5Y total return	200.51%
All Time High	121.1
All Time High Change	-56.21%
All Time High Date	2024-09-19
All Time Low	15.51
All Time Low Change	241.78%
All Time Low Date	2021-05-11
ATR	2.87
Beta	1.3
Beta1y	0.91
Beta2y	1.57
Ch YTD	14.89
High	53.39
High52	65
High52 Date	2026-02-25
High52ch	-18.45%
Low	50.82
Low52	28.64
Low52 Date	2025-05-14
Low52ch	85.09%
Ma50ch	-8.84%
Premarket Change Percent	1.79
Premarket Price	$52.4
Premarket Volume	1,316
Price vs 200-day SMA	13.62%
RSI	37.27
RSI Monthly	49.33
RSI Weekly	50.18
Sharpe ratio	1.38x
Sortino ratio	2.38
Total Return	-7.07%
Tr YTD	14.89
Tr1m	-12.65%
Tr1w	-6.89%
Tr3m	-5.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	2
Analyst Price Target Top	$113
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-1.79
Earnings Revenue Estimate	12,500,000x
Operating Income	$-1.1B
Price target	$88.25
Price Target Change	$66.48
Price Target Change Top	$113

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	132,711,358%
Float Percent	91.91%
Shares Insiders	0.67%
Shares Institutions	98.59%
Shares Out	144,397,682
Shares Qo Q	2.25%
Shares Yo Y	7.07%
Short Float	10.82%
Short Ratio	10.71
Short Shares	9.94

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-961.1M
Average Volume	1,403,103.3x
Bv Per Share	20.76
CAPEX	$-45M
Ch1m	-12.65
Ch1w	-6.89
Ch1y	82.79
Ch3m	-5.59
Ch3y	3.13
Ch5y	200.5
Ch6m	27.28
Change	2.97%
Change From Open	4.31
Close	51.48
Days Gap	-1.28
Depreciation Amortization	16,387,000
Dollar Volume	101,627,220.3
Earnings Date	2026-05-06
Earnings Time	amc
EBIT	$-1.1B
EBITDA	$-1.1B
EPS	$-6.91
F Score	1
FCF	$-814.9M
FCF EV Yield	-13.51x
FCF Per Share	$-5.64
Financing CF	602,838,000
Fiscal Year End	December
Founded	2,013
Investing CF	80,627,000
Ipr	231.3
Iprfo	154.9
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-24
Ma150	51.3
Ma150ch	3.34%
Ma20	58.94
Ma20ch	-10.06%
Net CF	-85,860,000
Next Earnings Date	2026-08-05
Open	50.82
Optionable	Yes
Position In Range	85.21
Post Close	53.01
Postmarket Change Percent	1.98
Postmarket Price	$54.06
Ppne	373,798,000
Pre Close	51.48
Price Date	2026-05-08
Ptbv Ratio	2.55
Relative Volume	1.37x
Share Based Comp	146,194,000
Tr6m	27.28%
Us State	California
Volume	1,917,133

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does PCVX pay a dividend?

Capital-return profile for this ticker.

Performance

PCVX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns PCVX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+98.6%

Float: +91.9% of shares outstanding

Insider ownership

+0.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

PCVX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.3

Neutral momentum band

Price vs 200-day MA

+13.6%

50/200-day relationship not available

Beta (5Y)

1.30

More volatile than the market

Sharpe ratio

1.38

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About PCVX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current PCVX stock rating?

Vaxcyte, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full PCVX analysis?

The full report lives at /stocks/PCVX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for PCVX?

The latest report frames PCVX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the PCVX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.